REJUVANAD+

REJUVANAD+ combines clinical precision with ease of use, making it an optimal choice for practitioners seeking consistent results and efficient preparation.

• Active Ingredient: Nicotinamide adenine dinucleotide (NAD⁺) in sterile solution.

• Strengths available: 100 mg/10 mL, 250 mg/10 mL, 500 mg/10 mL.

• Form: Clear, colorless solution for IV infusion.

• Single-use vials for maximum sterility.

• Manufactured in GMP-certified, FDA-compliant facilities.

• Batch-tested for potency, purity, and sterility.

• No preservatives or fillers.

• Ready-to-use — no reconstitution required.

REJUVANAD+ is indicated for clinical protocols where NAD⁺ replenishment supports recovery, energy restoration, and healthy cellular function. It is suitable for wellness, recovery, metabolic support, and healthy aging programs when administered under professional supervision.

Indications:

• Post-illness recovery for restoring cellular energy.

• Athletic recovery following intense physical exertion.

• Cognitive support for focus and mental clarity.

• Metabolic health support and healthy aging regimens.

Contraindications:

• Known hypersensitivity to NAD⁺ or any component of the formulation.

• Use only after medical evaluation to ensure patient suitability.

Side Effects:

• Mild, common: Warm sensation, flushing, headache, or mild chest tightness.

• Occasional: Nausea, dizziness, local irritation at the infusion site.

• Rare: Allergic reaction requiring immediate intervention.

• Reducing infusion rate can alleviate most mild reactions.

REJUVANAD+ contains a highly purified form of NAD⁺ in a sterile carrier solution, packaged for professional clinical use. Its minimalist composition ensures maximum efficacy and patient tolerance.

Ingredients:

• Active: Nicotinamide adenine dinucleotide (NAD⁺).

• Excipient: Water for Injection (WFI).

• No preservatives or added excipients.

Packaging:

• Clear, colorless solution in single-use 10 mL vials.

• Concentrations: 100 mg, 250 mg, 500 mg NAD⁺ per 10 mL.

• Protected in original packaging to maintain stability until use.

REJUVANAD+ must be administered by a trained healthcare professional in a clinical setting. It is intended exclusively for intravenous infusion and should never be self-administered.

Administration Guidelines:

• Route: Intravenous (IV) infusion only.

• Can be diluted in 0.9% sodium chloride solution.

• Infusion time: Typically 1–3 hours, adjusted to patient tolerance.

• Use aseptic technique throughout preparation and administration.

• Single-use vial — discard any unused product after the session.

Storage:

• Refrigerate at 2°C–8°C.

• Keep in original packaging until use to protect from light.

• Do not freeze.

• Shelf life: 24 months when stored as directed.